Phibro Animal Health (PAHC) Interest Expenses (2013 - 2026)
Phibro Animal Health (PAHC) posted quarterly Interest Expenses of $10.7 million for Q1 2026, up 10.65% year-over-year from $9.7 million in Q1 2025, and down 14.42% quarter-over-quarter from $12.5 million in Q4 2025.
Phibro Animal Health (PAHC) Interest Expenses (2013 - 2026) Analysis & Trends
Phibro Animal Health's Interest Expenses history runs 14 years deep, the most recent figure standing at $10.7 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 10.65% year-over-year to $10.7 million; the TTM figure through Mar 2026 stood at $44.7 million (up 57.31% YoY), while the FY2025 annual figure was $37.2 million, up 61.77% from the prior year.
- Interest Expenses for Q1 2026 stood at $10.7 million, down from $12.5 million in the prior quarter.
- The five-year high for Interest Expenses was $12.5 million in Q3 2025, with the low at $240000.0 in Q2 2024.
- The 5-year median for Interest Expenses is $5.6 million (2023), against an average of $6.8 million.
- The sharpest annual moves came in 2024 and 2025: Interest Expenses tumbled 95.59% in 2024, then soared 3661.67% in 2025.
- Phibro Animal Health's Interest Expenses stood at $4.6 million in 2022, then climbed by 23.66% to $5.7 million in 2023, then surged by 70.85% to $9.8 million in 2024, then rose by 27.64% to $12.5 million in 2025, then decreased by 14.42% to $10.7 million in 2026.
- Business Quant data shows PAHC's Interest Expenses at $10.7 million in Q1 2026, $12.5 million in Q4 2025, and $12.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Phibro Animal Health | 1.44 Bn | 1.36 Bn | 125.68 Mn | 10.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.68 Mn |
| Mar 31, 2026 | 10.68 Mn |
| Dec 31, 2025 | 12.48 Mn |
| Dec 31, 2025 | 12.48 Mn |
| Sep 30, 2025 | 12.54 Mn |
| Sep 30, 2025 | 12.54 Mn |
| Jun 30, 2025 | 9.03 Mn |
| Jun 30, 2025 | 9.03 Mn |
| Mar 31, 2025 | 9.65 Mn |
| Mar 31, 2025 | 9.65 Mn |
| Dec 31, 2024 | 9.78 Mn |
| Dec 31, 2024 | 9.78 Mn |
| Sep 30, 2024 | 8.77 Mn |
| Sep 30, 2024 | 8.77 Mn |
| Jun 30, 2024 | 240,000.00 |
| Jun 30, 2024 | 240,000.00 |
| Mar 31, 2024 | 5.65 Mn |
| Mar 31, 2024 | 5.65 Mn |
| Dec 31, 2023 | 5.72 Mn |
| Dec 31, 2023 | 5.72 Mn |